Johnson & Johnson Vaccine
-
Canada won’t limit J&J COVID-19 vaccine access due to rare blood clots: TamCanada's top doctor said Friday that there have been no cases of a rare blood clotting syndrome from Johnson & Johnson's COVID-19 vaccine so far in the country.CanadaMay 6, 2022
-
Johnson & Johnson temporarily halts COVID-19 vaccine production: reportJohnson & Johnson have temporarily shut down the only plant making usable batches of its COVID-19 vaccine, a New York Times report says.HealthFeb 8, 2022
-
COVID-19 vaccine maker Johnson & Johnson splitting into two companiesJohnson & Johnson, a medical manufacturing titan and COVID-19 vaccine maker, has announced it is dividing its business into two companies for better market impact.WorldNov 12, 2021
![]()
-
Health Canada adds autoimmune disorder warning to AstraZeneca, J&J COVID-19 vaccinesThe health agency said very rare cases of immune thrombocytopenia have been reported internationally after the AstraZeneca and Johnson & Johnson COVID-19 vaccines.HealthNov 9, 2021
![]()
-
B.C. to receive doses of Johnson & Johnson vaccine next weekThe single-dose vaccine will be offered to unvaccinated health-care workers as it might be a better option for those who are more vaccine-hesitant but want to keep working.HealthNov 9, 2021
![]()
-
Saskatchewan expecting Johnson and Johnson vaccine shipmentSaskatchewan could receive an allotment of the Johnson & Johnson single-dose vaccine by the end of the month if approved by the federal government.HealthNov 2, 2021
![]()
-
Johnson & Johnson eyes US$2.5B in COVID-19 vaccine sales despite Q3 slideJohnson & Johnson said it recorded US$766 million in sales of the shot in the first nine months of 2021, and would need sales to triple in the fourth quarter to meet its target.MoneyOct 19, 2021
![]()
-
FDA warns Johnson & Johnson COVID-19 vaccine linked to rare neurological reactionThe FDA flagged reports of Guillain-Barre syndrome, an immune system disorder that can cause muscle weakness and occasionally paralysis.WorldJul 12, 2021
![]()
-
Johnson & Johnson says its COVID-19 vaccine strong against Delta variant in new studyThe healthcare company said that its vaccine was 85 per cent effective and could also help prevent hospitalization and death against the highly transmissible strain.HealthJul 1, 2021
![]()
-
U.S. authorizes 14M more J&J COVID-19 vaccine doses from Baltimore factory: reportAll the J&J doses authorized from the plant to date are expected to be exported to other countries, one of the sources said.HealthJun 16, 2021
![]()
